title: Risk of HIV transmission under combined antiretroviral therapy: toward risk zero?
authors.affiliation: *Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Pierre Louis Institute of Epidemiology and Public Health, Paris, France †INSERM, UMR_S 1136, Pierre Louis Institute of Epidemiology and Public Health, Paris, France ‡Université Paris Descartes, Sorbonne Paris Cité, Faculté de Médecine, EA7327, Paris, France §APHP, Centre de Diagnostic et de Thérapeutique, Hôpital de l'Hôtel-Dieu, Paris, France ‖Institut Pasteur, Unité d'Epidémiologie des Maladies Emergentes, Paris, France.
authors.forename: Virginie
authors.initials: V
authors.lastname: Supervie
authors.forename: Jean-Paul
authors.initials: JP
authors.lastname: Viard
authors.forename: Dominique
authors.initials: D
authors.lastname: Costagliola
authors.forename: Romulus
authors.initials: R
authors.lastname: Breban
mesh_terms: D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active / Q000379:methods*; D018562:Disease Transmission, Infectious / Q000517:prevention & control*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000635:transmission*; D006801:Humans; D008297:Male; D012306:Risk; D018570:Risk Assessment
chemical_list: D044966:Anti-Retroviral Agents